Delivery Order SPE2DB22D1017-SPE2DB25FYRWU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,465.19 to AmerisourceBergen Drug Corp for the supply of ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This non-competitive, firm fixed-price delivery order was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,102.82 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This firm fixed price, non-set-aside delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,675.92 for ADDYI (flibanserin) 100 mg tablets in quantities of 30 units. This contract, issued on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded without set-aside designation under a firm fixed price structure. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $5,959.27 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of ADDYI (flibansergin) 100 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation, scheduled for ultimate completion on September 8, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.74 to AmerisourceBergen Drug Corp for ADDYI (flibanserin) 100 mg tablets in quantities of 30 on August 15, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price delivery order, which is not set-aside, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of ADDYI (flibanserrin) 100 mg tablets in quantities of 30 units. This competitive award, issued with no set-aside designation, carries a ceiling value of $5,740.71 and is priced on a firm fixed-price basis, with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserene) 100 mg tablets in quantities of 30 units, with a ceiling value of $41,739.01. This firm fixed price delivery order, awarded September 4, 2025, with ultimate completion by September 5, 2025, represents a competitive award with no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $6,091.21 delivery order on September 8, 2025, for ADDYI (flibanserin) 100 mg tablets in quantities of 30s. This is a firm fixed-price, non-set-aside contract with a completion date of September 9, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of ADDYI (flibanserins) 100 mg tablets in quantities of 30, with a ceiling value of $2,903.61. This firm fixed-price delivery order, which is expected to be completed by April 25, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a $5,184.18 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ADDYI (flibanserina) 100 mg tablets in quantities of 30 units. This delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The award was made through open competition with no set-aside designation. AmerisourceBergen, a major pharmaceutical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRWUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of ADDYI (flibanserins) 100 mg tablets in quantities of 30 count, valued at $3,654.47. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical procurement vendor with an extensive portfolio of pharmaceutical products and medical supplies. The company's federal contract awards through the DLA demonstrate its capability to supply a wide range of medications across multiple therapeutic domains to support military and veteran healthcare systems. This particular delivery order exemplifies the company's role in fulfilling specialized pharmaceutical needs within the federal supply chain, supporting the Defense Health Agency and other government healthcare entities through competitively awarded, firm fixed price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/24/25 |